The Global Nervous System Medicine sales highlight the United Kingdom as the leader with sales reaching 4.21 billion USD. Australia and Belgium follow, capturing significant markets with 1.62 and 1.06 billion USD respectively. Sweden, Austria, and Denmark also maintain stable positions. The year 2023 saw various country-specific trends, notably a slight decline in the UK's market with a -0.1% change, while Australia surged by 2.16%. Greece faced a notable downturn by 9.65%. Latvia and Estonia showed positive growth. A Compound Annual Growth Rate (CAGR) provides insights into consistent growth over the past five years.
Future trends will likely involve a higher incorporation of personalized medicine and advancement in neurological treatments, impacting market dynamics. Watch for shifts due to technological integration and demographic changes influencing demand across regions.
Top countries in Nervous System Medicine Sales by Country
| # | 9 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United Kingdom | 4,210 | 2023 | -0.12% | -0.1% | View data |
| 2 | 2 Australia | 1,620 | 2023 | +1.93% | +2.16% | View data |
| 3 | 3 Belgium | 1,060 | 2023 | +0.86% | +0.86% | View data |
| 4 | 4 Sweden | 920.2 | 2023 | +1.4% | +0.39% | View data |
| 5 | 5 Austria | 572.8 | 2023 | -0.42% | +2% | View data |
| 6 | 6 Denmark | 568.5 | 2023 | +1.81% | +1.36% | View data |
| 7 | 7 Greece | 477.2 | 2023 | -17.12% | -9.65% | View data |
| 8 | 8 Latvia | 55.6 | 2023 | 0% | +3.82% | View data |
| 9 | 9 Estonia | 41.7 | 2023 | +1.96% | +4.6% | View data |
